T-cell re-population in HIV-infected children on highly active anti-retroviral therapy (HAART)

Clin Exp Immunol. 2001 Sep;125(3):447-54. doi: 10.1046/j.1365-2249.2001.01616.x.

Abstract

In this pilot study, we address the nature of the re-population of the T-cell compartment in HIV-1+ (Human Immunodeficiency Virus 1), vertically infected children placed on successful regimens of HAART (highly active anti-retroviral therapy) incorporating 2 NRTI and a protease inhibitor. The clonality of the T-cell compartment and the abundance of RTEs (Recent Thymic Emigrants) were determined 2 weeks before and 20 weeks after initiation of HAART in a subgroup of children taking part in the PENTA (Paediatric European Network for the Treatment of AIDS) 5 trial. Analysis of the clonality of the circulating T-cell compartment was assessed using CDR3 spectratyping and analysed using the Kolmogorov-Smirnov two sample test. This revealed that a high degree of T-cell clonal restriction still exists 5 months into therapy, despite the appearance of previously undetectable T-cell clones within the periphery. We detected no increase in RTE abundance in this 5 month period, as determined by PCR detection of TRECs (T-Cell Receptor Excision Circles). We conclude that the observed re-population of T cells within the periphery of treated children is heavily reliant upon the maintenance/expansion of pre-existing cells during the 5 month period immediately following the initiation of therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antiretroviral Therapy, Highly Active*
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Complementarity Determining Regions
  • Genes, T-Cell Receptor beta
  • HIV Infections / immunology*
  • HIV Infections / transmission
  • Humans
  • Infectious Disease Transmission, Vertical
  • Lymphocyte Count
  • Pilot Projects
  • T-Lymphocytes / cytology
  • T-Lymphocytes / immunology*

Substances

  • Complementarity Determining Regions